TransIT®-LT1 Transfection Reagent
TransIT®-LT1 Transfection Reagent from Mirus Bio- A broad spectrum, low toxicity, DNA transfection reagent • Broad Spectrum DNA Delivery - Utilize one transfection reagent and protocol for a variety of cells. • Low Cellular Toxicity - Maintain cell density and reduce experimental biases. • High Efficiency Delivery - Achieve expression in a large population of cells for experimental success. • Deliver Single or Multiple Plasmi…
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
TransIT®-LT1 Transfection Reagent from Mirus Bio- A broad spectrum, low toxicity, DNA transfection reagent
• Broad Spectrum DNA Delivery - Utilize one transfection reagent and protocol for a variety of cells.
• Low Cellular Toxicity - Maintain cell density and reduce experimental biases.
• High Efficiency Delivery - Achieve expression in a large population of cells for experimental success.
• Deliver Single or Multiple Plasmids - Suitable for many applications such as gene expression, shRNA expression, viral production, and promoter analysis.
High Efficiency Production of LentiviralVectors in HEK 293FT Cells Using Plasmid Co-transfection: Calcium Phosphate vs. Lipopolyplex Transfection
Lentiviral vectors are quickly becoming a vector of choice for many in vivo gene delivery and RNA interference applications. However, lentiviral vector production remains a time consuming and relatively low yield process. This study compares the efficiency of viral production using a standard calciumphosphate protocol versus a protocol using a high efficiency, low toxicity, lipopolyplex formulation (TransIT®-LT1Reagent).
The Impact of Transfection Mediated Toxicity - Gene Expression and Cytotoxicity Analysis of Transfection Reagents
While plasmid DNA delivery is a widely used method to study cellular functions of proteins of interest, studies to identify nontoxic gene delivery reagents are limited. This application note presents a study which explores the conventional toxicological endpoints, and identifies the minimal-transcriptomic effects, of TransIT®‐LT1, TransIT®‐2020 and Lipofectamine® 2000 Transfection Reagents using quantitative reverse transcriptase PCR (RT‐qPCR) array and pathway analysis software.
